Recent Complications and Issues in Tuberculosis Treatment

Title:Recent Complications and Issues in Tuberculosis Treatment

Volume: 12 Issue: 2

Author(s): Mohammad Taleuzzaman*Vinay Kumar

Affiliation:

• Glocal School of Pharmacy, Glocal University, Saharanpur, U.P.,India

Keywords: Tuberculosis, diffusion probability, pathophysiology, microscopic sputum, echocardiography, hepatotoxicity.

Abstract: Background: Tuberculosis is one of the major communicable diseases which can be prevented and cured. The prevalence of tuberculosis infection is more despite this disease causes major morbidity and mortality. To establish connection between tuberculosis (TB) related stigma and hindrance in search of a treatment after the inception of symptoms associated with tuberculosis.

Methods: Physicians conducted the interviews using a structured questionnaire. Information from the medical reports available at health care centers (especial results of sputum microscopy, radiological and other investigations) was also distracted. Patients is said to be infected with TB having a minimum two initial +ve sputum smears or one +ve sputum smear and chest radiographic abnormalities along with active pulmonary TB as determined by clinician; one sputum +ve culture specimen +ve for Mycobacterium tuberculosis. High resolution computed tomography (HRCT), a new susceptible technique shows erratically disseminated military nodules. The organs associated and extents of lesions of miliary TB in the pulmonary tuberculosis are examined by ultrasonography, computed tomography (CT) and magnetic resonance imaging (MRI). Histopathological examination of tissue biopsy is a conservative and fast technique for the separation of mycobacterium tuberculosis and assessment of choroid tubercles in fundus.

Conclusion: Even though numerous prognostic markers have been described which envisage mortality, yet untreated miliary TB has a serious outcome within one year. A high index of clinical research, early diagnosis and timely institution of anti-tuberculosis treatment can be life-saving. Response to first-line anti-tuberculosis drugs is good. Anti–tuberculosis drugs are patent.

Cite this article as:

Taleuzzaman Mohammad*, Kumar Vinay, Recent Complications and Issues in Tuberculosis Treatment, Recent Patents on Anti-Infective Drug Discovery 2017; 12 (2) . https://dx.doi.org/10.2174/1574891X12666171006104430